The end point change on a website means little now.
trocpoint’s post is about right for me.
“Disagree. Patience is gone. We need competent adults in the room. This was a terrible strategy from the start. Whoever convinced LP to go into a 19 month quiet period is a moron. BTW, they hired outside consultants, most likely academics (who have never run a business, much less a public company) to recommend a plan.
We need an immediate pivot and an offensive strategy. Clinicaltrials endpoint changes and even a Journal can be lost into the abyss if these negative attacks with no response from the company continue. You only get one chance for a first impression and so far we have egg on our face.”